Global AIDS Update 2018
Closing Gaps
Breaking Barriers
Righting injustices
Special summit of African Union on HIV and Aids, Tuberculosis and Malaria (atm) Abuja, Nigeria 2–4 may, 2006Sp/Assembly/ATM/2 (I), Rev.3
Abuja call for accelerated action towards universal access to HIV and Aids, Tuberculosis and Malaria services in Africa
BMJ,Dodd PJ, et al. Thorax 2017;72:559–575. doi:10.1136/thoraxjnl-2016-209421
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...ections. Clofazimine resistance is still rare but this antimicrobial cannot be given alone
more
The long-term goal of AIDSFree is to improve the quality and effectiveness of high-impact, evidence-informed HIV and AIDS interventions. This semiannual performance report (SAPR) summarizes AIDSFree's achievements for the period October 1, 2015–March 31, 2016
ACAPS Primary Data Collection report: November 2015.
This report reflects the views and voices of 53 university students in Sierra Leone and results from a focus group discussion held at the Geography Department, at Fourah Bay College, University of Sierra Leone, Freetown, on 20 October 2015. As th...e response moves towards recovery and long-term development planning, the perceptions of the younger generation on the crisis highlight their priorities for the future.
more
Глобальная статистика свидетельствует о том, что бремя туберкулеза более актуально в городских регионах. Тем не менее, в тех странах, где большая часть населения п...оживает в сельской местности в условиях крайней нищеты, туберкулез является доминирующей проблемой среди сельских жителей. Бедность и ограниченный доступ к медицинским учреждениям и медицинским работникам значительно снижают способность людей с туберкулезом, проживающих в сельской местности, получить своевременную диагностику и лечение.
Accessed on 2019
more
Journal of Microbiology and Infectious Diseases / 2015; 5 (3): 110-113
JMID, doi: 10.5799/ahinjs.02.2015.03.0187
Presentation is current through November 21, 2014 and will be updated every Friday by 5pm. For the most up-to-date information, please visit www.cdc.gov/ebola.
*Presentation contains materials from CDC, MSF, and WHO
Principles and Target Product Criteria. Roadmap January 12, 2015